← FDA Drug Approvals (Drugs@FDA)

ERLOTINIB HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2022-06-22

Drug application

FDA Application #

ANDA216342

Application type

Abbreviated New Drug Application (Generic)

Brand name

ERLOTINIB HYDROCHLORIDE

Generic name

ERLOTINIB

Active ingredients

ERLOTINIB HYDROCHLORIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

EUGIA PHARMA

Manufacturer

Aurobindo Pharma Limited

First approval

2022-06-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown